← All Sponsors
SPONSOR

Pharmicell Co., Ltd.

Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Alcoholic Cirrhosis
NCT05093881
Recruiting

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Alcoholic Cirrhosis
South Korea View Trial →
NCT04689152 Phase 3
Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

Alcoholic Cirrhosis
South Korea View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology